Literature DB >> 2206908

Regulation of renal phosphate reabsorption during development: implications from a new model of growth hormone deficiency.

A Haramati1, S E Mulroney, M D Lumpkin.   

Abstract

It has been hypothesized that the high rate of renal phosphate (Pi) reabsorption in the immature animal is a consequence of the increased demand for Pi associated with the rapid rate of growth. Although growth hormone (GH) has been proposed to play a role in this process, investigations of the relationship between GH, growth and the renal Pi transport have been hampered by the lack of methods available to specifically alter circulating GH levels. This review summarizes the findings from recent studies using a newly developed peptidic antagonist to GH-releasing factor (GRF-AN) as a method of specifically inhibiting GH release. Systemic injection of GRF-AN was effective in suppressing the pulsatile release of GH, and in significantly attenuating the rate of growth, in both immature and adult rats. However, the inhibition of growth was associated with a reduction in net Pi retention only in immature rats, resulting in a doubling in the urinary excretion of Pi. GRF-AN treatment of immature rats lead to a decrease in the maximum tubular capacity to transport Pi-down to the level seen in adult rats. However, GRF-AN treatment did not alter renal Pi reabsorption in adult rats. We conclude that chronic administration of an antagonist to GRF in rats provides a new model of GH deficiency with which to study the interrelationships between growth, GH and other physiological systems. Furthermore, the findings suggest that the pulsatile release of GH, directly or indirectly, contributes to the high rate of renal Pi reabsorption in young, growing animals and may play a critical role in regulating Pi homeostasis during development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206908     DOI: 10.1007/bf00862524

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  EFFECT OF GROWTH HORMONE ON TUBULAR TRANSPORT OF PHOSPHATE IN NORMAL AND PARATHYROIDECTOMIZED DOGS.

Authors:  J CORVILAIN; M ABRAMOW
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  Tubular handling of Pi in young growing and adult rats.

Authors:  J Caverzasio; J P Bonjour; H Fleisch
Journal:  Am J Physiol       Date:  1982-06

3.  Antagonist to GH-releasing factor inhibits growth and renal Pi reabsorption in immature rats.

Authors:  S E Mulroney; M D Lumpkin; A Haramati
Journal:  Am J Physiol       Date:  1989-07

4.  Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist.

Authors:  M D Lumpkin; J K McDonald
Journal:  Endocrinology       Date:  1989-03       Impact factor: 4.736

5.  Regulation of canine renal vesicle Pi transport by growth hormone and parathyroid hormone.

Authors:  M R Hammerman; I E Karl; K A Hruska
Journal:  Biochim Biophys Acta       Date:  1980-12-12

6.  Renal reabsorption of phosphate during development: whole-kidney events.

Authors:  V Johnson; A Spitzer
Journal:  Am J Physiol       Date:  1986-08

7.  Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient rats.

Authors:  R G Clark; I C Robinson
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

8.  Developmental changes in the tubular capacity for phosphate reabsorption in the rat.

Authors:  A Haramati; S E Mulroney; S K Webster
Journal:  Am J Physiol       Date:  1988-08

9.  Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes.

Authors:  P Robberecht; D H Coy; M Waelbroeck; M L Heiman; P de Neef; J C Camus; J Christophe
Journal:  Endocrinology       Date:  1985-11       Impact factor: 4.736

10.  Structure-activity studies on the N-terminal region of growth hormone releasing factor.

Authors:  D H Coy; W A Murphy; J Sueiras-Diaz; E J Coy; V A Lance
Journal:  J Med Chem       Date:  1985-02       Impact factor: 7.446

View more
  2 in total

Review 1.  Recombinant growth hormone therapy for X-linked hypophosphatemia in children.

Authors:  Sherie Smith; Tracey Remmington
Journal:  Cochrane Database Syst Rev       Date:  2021-10-07

2.  Age-associated and breed-associated variations in haematological and biochemical variables in young labrador retriever and miniature schnauzer dogs.

Authors:  Thomas Brenten; Penelope J Morris; Carina Salt; Jens Raila; Barbara Kohn; Florian J Schweigert; Jürgen Zentek
Journal:  Vet Rec Open       Date:  2016-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.